3,5-Bis(arylidene)-4-piperidonesaspotential dengue proteaseinhibitors
Dengue isaseveremosquito-borneviralinfectioncausinghalfamilliondeathsannually. Dengue virusNS2B/NS3proteaseisavalidatedtargetforanti-denguedrugdesign.Aseriesofhitherto unreported 3,5-bis(arylidene)-4-piperidonesanalogues 4a–4j were synthesizedandscreened in silico against DENV2NS2B/NS3proteasetoe...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Published: |
Elsevier
2017
|
Subjects: | |
Online Access: | http://eprints.usm.my/36660/ http://dx.doi.org/10.1016/j.apsb.2017.04.009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Sains Malaysia |
Summary: | Dengue isaseveremosquito-borneviralinfectioncausinghalfamilliondeathsannually.
Dengue virusNS2B/NS3proteaseisavalidatedtargetforanti-denguedrugdesign.Aseriesofhitherto
unreported 3,5-bis(arylidene)-4-piperidonesanalogues 4a–4j were synthesizedandscreened in silico
against DENV2NS2B/NS3proteasetoelucidatetheirbindingmechanismandorientationaroundthe
active sites.Resultswerevalidatedthroughan in vitro DENV2 NS2B/NS3proteaseassayusinga
fluorogenic Boc-Gly-Arg-Arg-AMCsubstrate.Nitroderivativesof3,5-bis(arylidene)-4-piperidones(4e
and 4j) emergedaspromisingleadmoleculesfornovelproteaseinhibitorswithanIC50 of 15.22and
16.23 mmol/L, respectively,comparedtothestandard,panduratinA,havingIC50 of 57.28 mmol/L. |
---|